Ramatroban

Ramatroban

SCHEMBL9869501

O=C([O-])CCn1c2c(c3ccccc31)CC(NS(=O)(=O)c1ccc(F)cc1)CC2.[Na+]

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGDR2TBXA2R

The experimentally established mechanism targets of Ramatroban. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PTGDR2 known ✓ Q9Y5Y4 18/20 0.85
TBXA2R known ✓ P21731 8/20 0.85
PTGDR Q13258 6/20 0.85
ABCB11 O95342 1/20 0.85
CYP2C9 P11712 1/20 0.85
DRD1 P21728 1/20 0.85
CCKAR P32238 1/20 0.85
RB1 P06400 1/20 0.48
HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ramatroban SCHEMBL1427849 1.00 PTGDR2 (0.85) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL29031 0.92 PTGDR2 (1.00) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL29030 0.92 PTGDR2 (1.00) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL29503087 0.92 PTGDR2 (1.00) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL1427851 0.92 PTGDR2 (1.00) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL20769768 0.92 PTGDR2 (1.00) PTGDR2TBXA2RPTGDRABCB11CYP2C9
SCHEMBL9870632 0.91 PTGDR2 (0.70) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL1427848 0.91 PTGDR2 (0.98) PTGDR2TBXA2RPTGDRABCB11CYP2C9
SCHEMBL9429657 0.91 PTGDR2 (0.85) PTGDR2TBXA2RPTGDRABCB11CYP2C9
Ramatroban SCHEMBL1427850 0.91 PTGDR2 (0.98) PTGDR2TBXA2RPTGDRABCB11CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4988820-A Inhibiting platelet aggregation, anticoagulants, thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1991-01-29 US disclosed
US-4965258-A Anticoagulant; thromboxane a2 antagonist BAYER AKTIENGESELLSCHAFT (DE) 1990-10-23 US disclosed
US-4904797-A REACTING A (BENZENESULFONAMIDOALKYL)CYCLOALKANO(1,2-B)INDOLE WITH ACRYLONITRILE; HYDROLYSIS, HYDROGENATION, REDUCTION BAYER AKTIENGESELLSCHAFT (DE) 1990-02-27 US disclosed
US-4827032-A INTERMEDIATES FOR ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 1989-05-02 US disclosed